Your browser doesn't support javascript.
loading
[ role of bisphosphonate in the treatment of bone metastases from prostate cancer]
Tunisie Medicale [La]. 2012; 90 (7): 507-511
en Francés | IMEMR | ID: emr-151864
ABSTRACT
Bone metastasis is very frequent in prostate cancer. It is a turning point that marks the severity of the disease. Before metastasis become symptomatic, treatment preventing bone events should be indicated. To evaluate the role of bisphosphonate in the treatment of bone metastases from prostate cancer. A review of literature. Bisphosphonates play a very important role to prevent bone mass loss and to reduce bone complication events. Bisphosphonates are recommended as preventive treatment at the time of diagnosis of bone metastatic prostate cancer
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Francés Revista: Tunisie Med. Año: 2012

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Francés Revista: Tunisie Med. Año: 2012